Oncovaccine against colorectal cancer may begin to be used this year.

"Due to the fact that last year the law on the use of personalized medicines was adopted, developed on the initiative of the agency, starting this year it is possible to use a vaccine against colorectal cancer in a patient," she said during a speech at the Women for a Healthy Society forum.

According to Skvortsova, the cancer vaccine will not be able to replace existing methods of treating diseases, but it will be a good addition.

Tread marks: there is a shortage of an unparalleled drug for cancer patients in the Russian Federation

How long will the mesna reserves last and when will the country have its own production?

At the forum "Women for a Healthy Society", the head of the FMBA also reported href="https://iz.ru/1848596/2025-03-04/v-fmba-zavershili-doklinicheskoe-issledovanie-protivoopukholevogo-preparata " target="_blank">on completion of preclinical studies of antitumor genetically engineered drug for oncological diseases. Skvortsova clarified that the drug carries two protoxin genes that are activated in tumor cells and trigger their death mechanisms.